arginine vasopressin has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XY; Li, T; Liu, LM; Wu, Y; Zhu, Y | 1 |
| Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Wenzel, V | 1 |
2 other study(ies) available for arginine vasopressin and Hyperlipemia
| Article | Year |
|---|---|
DIVERSITY OF VASCULAR REACTIVITY AND THE TREATMENT RESPONSE IN DIABETIC, HYPERTENSIVE, HYPERLIPIDEMIC, AND HEALTHY RATS SUBJECTED TO HEMORRHAGIC SHOCK.
Topics: Animals; Arginine Vasopressin; Diabetes Mellitus; Dopamine; Female; Hemodynamics; Hyperlipidemias; Hypertension; Male; Mitochondria; Norepinephrine; Phorbol Esters; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Vasoconstriction | 2016 |
[Vasopressin as a rescue vasopressor agent. Treatment of selected cardiogenic shock states].
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Blood Pressure; Critical Illness; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pulmonary Wedge Pressure; Sepsis; Shock, Cardiogenic; Treatment Outcome; Vasoconstrictor Agents | 2007 |